Wall Street Sees Downbeat Session Amid Data

An image of a pen on an open laptop
Credit: Shutterstock photo

US stocks were set for a downbeat session Tuesday amid the release of a string of economic data.

Oil prices nudged higher with global benchmark Brent crude up 0.86%, and US West Texas Intermediate crude up 0.93% recently as tensions on the Israeli-Gaza border continued to feed oil-flow concerns in the region.

Data released at 8:30 am showed retail sales rose a moderate 0.3% as expected in April vs the prior month's revised reading of an 0.8% gain. The Empire State general business conditions index came in at 20.1 in May vs April's 15.8 and expectations for 15.5, according to data compiled by Econoday.

At 8:55 am, data showed Redbook store sales rose 4.9% for the May 12 week vs the prior week's increase of 4.2%.

At 10 am, forecasters see a modest 0.2% rise in business inventories for March vs the prior reading of a 0.6% increase. The consensus calls for no change in the housing market index at 69 for May.

In equities, shares of SORL Auto Parts ( SORL ) were trading 14.5% higher pre-bell after the company reported year-over-year increases in its Q1 financial results.


-Dow Jones Industrial down 0.52%

-S&P 500 futures down 0.42%

-Nasdaq 100 futures down 0.68%

-Nasdaq 100 pre-market indicator down 0.38%


Nikkei down 0.21%

Hang Seng down 1.23%

Shanghai Composite up 0.57%

FTSE-100 down 0.96%

DAX-30 up 0.34%


(-) Large cap tech: unchanged to lower

(-) Chip stocks: unchanged to lower

(-) Software stocks: lower

(-) Hardware stocks: unchanged to lower

(-) Internet stocks: lower

(+/-) Oil stocks: mixed

(-) Biotech stocks: unchanged lower

(-) Drug stocks: unchanged to lower

(-) Financial stocks: lower

(+/-) Retail stocks: mixed

(+/-) Industrial stocks: mixed

(-) Airlines: unchanged to lower

(+/-) Autos: mixed


(+) MSCC (+1.3%) Microchip gets antitrust clearance in China, Japan, Philippines, Germany and Austria for acquisition of Microsemi

(+) INO (+10.6%) HIV vaccine sustains durable memory responses one year after start of clinical trial

(+) CLWT (+47.8%) 2017 profit rises, revenue declines year-over-year


(-) VIPS (-15.2%) Q1 earnings shy of estimates

(-) HD (-2.3%) Q1 earnings top estimates, misses on revenue

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 All rights reserved. Unauthorized reproduction is strictly prohibited.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Other Topics


Latest Markets Videos


Founded in 1999, MT Newswires (formerly known as Midnight Trader) is a leading provider of original source, multi-asset class, real-time, global financial news and information to most of the largest banks, brokerage firms and professional market data, trading & research applications in North America.

Learn More